nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.224	0.432	CbGbCtD
Promazine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.187	0.359	CbGbCtD
Promazine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.109	0.209	CbGbCtD
Promazine—Oxcarbazepine—ALB—focal segmental glomerulosclerosis	0.00144	0.218	CrCbGaD
Promazine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.00108	0.165	CrCbGaD
Promazine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.00106	0.161	CrCbGaD
Promazine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.00104	0.159	CrCbGaD
Promazine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.000824	0.125	CrCbGaD
Promazine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.000565	0.0861	CrCbGaD
Promazine—Amitriptyline—ALB—focal segmental glomerulosclerosis	0.000559	0.0851	CrCbGaD
Promazine—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000253	0.000535	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000252	0.000533	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000252	0.000531	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000249	0.000526	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000248	0.000525	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000248	0.000524	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000247	0.000522	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000243	0.000512	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000242	0.000511	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00024	0.000508	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00024	0.000507	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000237	0.0005	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000236	0.000499	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000236	0.000497	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000234	0.000494	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000233	0.000492	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000233	0.000492	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000233	0.000491	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000232	0.00049	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000232	0.000489	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000231	0.000487	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00023	0.000486	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00023	0.000486	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00023	0.000485	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000229	0.000484	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000229	0.000483	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000228	0.000482	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000227	0.000479	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000226	0.000478	CbGpPWpGaD
Promazine—CHRM3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000226	0.000477	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000226	0.000476	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00022	0.000465	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000216	0.000456	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000214	0.000452	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000213	0.000451	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000213	0.00045	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000212	0.000448	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000211	0.000445	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000211	0.000445	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00021	0.000444	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00021	0.000443	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00021	0.000443	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00021	0.000442	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00021	0.000442	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000209	0.000441	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000209	0.000441	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000209	0.000441	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000208	0.00044	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000208	0.00044	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000208	0.00044	CbGpPWpGaD
Promazine—CHRM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000208	0.000439	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000208	0.000438	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000207	0.000438	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000207	0.000437	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000207	0.000437	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000206	0.000435	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000206	0.000435	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000206	0.000434	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000205	0.000433	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000204	0.000432	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000204	0.00043	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000202	0.000427	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000201	0.000424	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000198	0.000417	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000196	0.000413	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000195	0.000411	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000194	0.00041	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000194	0.000409	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000192	0.000406	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000192	0.000405	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000191	0.000404	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000191	0.000403	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000191	0.000403	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000191	0.000403	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00019	0.000402	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00019	0.000401	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00019	0.0004	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000188	0.000396	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000187	0.000395	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000187	0.000395	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000187	0.000394	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000185	0.00039	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000185	0.00039	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000183	0.000387	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000181	0.000382	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000178	0.000377	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000178	0.000376	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000178	0.000376	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000178	0.000375	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000177	0.000374	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000177	0.000373	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000176	0.000371	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000175	0.00037	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000175	0.00037	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000175	0.000369	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000174	0.000367	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000174	0.000367	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000172	0.000364	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000172	0.000363	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000169	0.000357	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000168	0.000355	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000167	0.000352	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000167	0.000352	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000166	0.000351	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000163	0.000345	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000161	0.000339	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00016	0.000338	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00016	0.000337	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00016	0.000337	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00016	0.000337	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000159	0.000336	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000158	0.000333	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000157	0.000332	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000157	0.000331	CbGpPWpGaD
Promazine—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000157	0.000331	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000156	0.00033	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000154	0.000325	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000152	0.000322	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000152	0.000321	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000152	0.000321	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000152	0.000321	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00015	0.000317	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00015	0.000317	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00015	0.000317	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000147	0.000311	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000147	0.000311	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000147	0.00031	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000146	0.000308	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000146	0.000307	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000144	0.000304	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000144	0.000303	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000141	0.000297	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000139	0.000293	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000138	0.000292	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000138	0.000291	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000137	0.000289	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000136	0.000287	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000136	0.000287	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000135	0.000286	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000135	0.000286	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000135	0.000285	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000134	0.000283	CbGpPWpGaD
Promazine—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000134	0.000283	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000134	0.000283	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000134	0.000282	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000133	0.000281	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000132	0.000279	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000132	0.000278	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000131	0.000277	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000131	0.000276	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00013	0.000275	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00013	0.000274	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00013	0.000274	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00013	0.000274	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000129	0.000273	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000128	0.000271	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000127	0.000268	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000125	0.000264	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000125	0.000264	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000125	0.000263	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000124	0.000263	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000124	0.000262	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000124	0.000261	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000123	0.00026	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000123	0.00026	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000123	0.000259	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000123	0.000259	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000122	0.000259	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00012	0.000254	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00012	0.000254	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000117	0.000247	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000117	0.000247	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000115	0.000244	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000115	0.000243	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000115	0.000242	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000114	0.000242	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000114	0.00024	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000113	0.000239	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000113	0.000238	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000112	0.000237	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000112	0.000237	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000111	0.000234	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000111	0.000234	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000106	0.000224	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000105	0.000223	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000104	0.00022	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000104	0.00022	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000104	0.000219	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000104	0.000219	CbGpPWpGaD
Promazine—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000103	0.000217	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000103	0.000217	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000103	0.000216	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000102	0.000216	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	0.000102	0.000215	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	0.0001	0.000212	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.0001	0.000211	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.95e-05	0.00021	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.82e-05	0.000207	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.58e-05	0.000202	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.5e-05	0.000201	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	9.43e-05	0.000199	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.4e-05	0.000198	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	9.28e-05	0.000196	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.96e-05	0.000189	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.84e-05	0.000187	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	8.83e-05	0.000186	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.83e-05	0.000186	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	8.71e-05	0.000184	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.69e-05	0.000183	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.67e-05	0.000183	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.64e-05	0.000182	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.61e-05	0.000182	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.53e-05	0.00018	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.51e-05	0.00018	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.2e-05	0.000173	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.14e-05	0.000172	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.09e-05	0.000171	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	7.94e-05	0.000168	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	7.93e-05	0.000167	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.9e-05	0.000167	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.75e-05	0.000164	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.66e-05	0.000162	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.38e-05	0.000156	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.34e-05	0.000155	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.28e-05	0.000154	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	6.79e-05	0.000143	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.76e-05	0.000143	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	6.68e-05	0.000141	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.66e-05	0.00014	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.64e-05	0.00014	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.62e-05	0.00014	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.6e-05	0.000139	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.53e-05	0.000138	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.52e-05	0.000138	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.32e-05	0.000133	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	6.12e-05	0.000129	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	6.09e-05	0.000129	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.05e-05	0.000128	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.05e-05	0.000128	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.57e-05	0.000118	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.48e-05	0.000116	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.47e-05	0.000116	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.46e-05	0.000115	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.44e-05	0.000115	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.39e-05	0.000114	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.37e-05	0.000113	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	5.24e-05	0.000111	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	5.21e-05	0.00011	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.99e-05	0.000105	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	4.02e-05	8.49e-05	CbGpPWpGaD
